Dr. Irene Wu has completed Bachelor in Preventive Medicine, Master in Epidemiology and Health Statistics, and a PhD in clinical epidemiology. She received her post-doctoral training in the Chinese University of Hong Kong, focusing on developing methods for evaluating traditional, complementary and integrative medicine in an evidence based manner. Dr. Wu received the prestigious award of “High-level Talents Introduction Plan” from Central South University in 2018, and is currently a Professor in the Xiangya School of Public Health, Central South University. As a well-trained epidemiologist and biostatistician with focus on evidence based healthcare, Dr Wu has a good research track record in in evidence based integrative medicine, of which she has published over 60 articles in international peer reviewed journals. Dr Wu has conducted several projects to comprehensively summarize evidence from Chinese medicine for cancer palliative care and gastrointestinal diseases (including irritable bowel syndrome and functional dyspepsia). She is among the first researchers who applied network meta-analysis for evaluating comparative effectiveness of different Chinese medicine interventions. In her post-doctoral training, Dr Wu has developed an online course on evidence based healthcare, attracting more than 30,000 access to the website access since its launch in 2017. Dr Wu has obtained several research and knowledge translation grants as either principal investigator or co-investigator from the Hong Kong Government. Currently, Dr Wu focuses on methodological issue around model validity of Chinese medicine evaluation.By conducting meta-epidemiological study, her team aims to compare the comparative effectiveness of individualized and standardized treatment using Chinese herbal medicine. Dr Wu is part of the Hong Kong team in the development of Clinical and Health Intervention Meta-analysis Evidence RAting System (CHIMEREAS), which is now implemented in grading quality of evidence for 200 synopses on integrative medicine She has recently completed a randomized controlled trial to compare the performance between GRADE and CHIMERAS, which has been accepted as a long-oral presentation by the 25th Cochrane Colloquium (16-18, Sep 2018, Edinburgh, United Kingdom). Dr Wu is a member of Editorial Board of European Journal of Integrative Medicine, and a peer reviewer for several international journals, including BMJ, Journal of Ethnopharmacology, Phytomedicine, BMJ Open, Scientific Reports and PLOS ONE.